CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 15 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, 5 late-stage candidates are at pivotal trials. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become globally recognized as a leading Chinese biopharmaceutical company by bringing innovative oncology therapies to cancer patients worldwide.

More information about click here: CStone

Kaleidoscope Data Privacy Consultants (KDPC) is the EEA Representative for the purposes of the General Data Protection Regulation (GDPR) for CStone.

If you have a question about how your personal data is processed, please select your preferred language from the menu on the left. Here you will find details on how to contact Kaleidoscope Data Privacy Consultants including a form to request a telephone call or submit your question online.

Translate